Bupivacaine

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameBupivacaine
Drug Alias NameBupiZengeCLXONC-17LBS-1011CLX-117
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsBack PainPain, PostoperativeHypotension +[11
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPakistanEgypt
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCellix Bio Pvt Ltd
China Registration ClassN/A

Develop Information

Active IndicationsBack PainPain, PostoperativeHypotension +[10
Inactive IndicationsAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A